scispace - formally typeset
X

Xiao Yu Wu

Researcher at University of Toronto

Publications -  182
Citations -  9994

Xiao Yu Wu is an academic researcher from University of Toronto. The author has contributed to research in topics: Drug carrier & Drug delivery. The author has an hindex of 49, co-authored 173 publications receiving 8485 citations. Previous affiliations of Xiao Yu Wu include McMaster University & Nanjing University.

Papers
More filters
Journal ArticleDOI

Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles

TL;DR: The prospect of improved cancer chemotherapy using solid lipid nanoparticles (SLN) as a drug delivery system is promising and it is anticipated that, in the near future, SLN will be further improved to deliver anticancer compounds in a more efficient, specific and safer manner.
Journal ArticleDOI

Multifunctional albumin-MnO₂ nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response.

TL;DR: Combination treatment of the tumors with NPs and ionizing radiation significantly inhibited breast tumor growth, increased DNA double strand breaks and cancer cell death as compared to radiation therapy alone, and suggest great potential of A-MnO2 NPs for modulation of the TME and enhancement of radiation response in the treatment of cancer.
Journal ArticleDOI

Nanotechnological advances for the delivery of CNS therapeutics

TL;DR: Future development of CNS nanomedicines need to focus on increasing their drug-trafficking performance and specificity for brain tissue using novel targeting moieties, improving their BBB permeability and reducing their neurotoxicity.
Journal ArticleDOI

The kinetics of poly( N -isopropylacrylamide) microgel latex formation

TL;DR: In this paper, the conversion versus time curves were measured for poly(N-isopropylacrylamide) microgel latexes prepared by polymerization in water with sodium dodecyl sulfate, SDS.
Journal ArticleDOI

A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System

TL;DR: It is suggested that some of the Dox physically associated with the nanoparticles bypass the membrane-associated Pgp when delivered as Dox-PLNs, and in this form, the drug is better retained within the Pgp-overexpressing cells than the free drug.